InnovAge Holding Corp. (INNV) Key Metrics

NASDAQ: INNVValuation, returns, debt and efficiency ratios over 10 years.

INNV valuation today

Trailing 12 months · as of October 18, 2026
Market cap
$1.21B
Enterprise value
$1.17B
P/E (TTM)
—
Forward P/E
13.7
PEG ratio
—
Price / sales
1.2
10-yr median 0.9
Price / book
5.2
10-yr median 2.7
EV / EBITDA
45.7
10-yr median 53.6
Dividend yield
—
Beta
0.15

INNV key metrics, FY2017–FY2026

Fiscal year ended June 30, 2026 · U.S. dollars

INNV valuation Price multiples at each fiscal year-end price.

Price / sales+177.6%
1.6
FY2026 · hover or tap a bar for each year
FY2019: 0.4FY2021: 4.5FY2022: 0.8 (−81.2%)FY2023: 1.5 (+74.0%)FY2024: 0.9 (−40.3%)FY2025: 0.6 (−33.7%)FY2026: 1.6 (+177.6%)
FY2017FY2026
Price / book+221.0%
6.8
FY2026 · hover or tap a bar for each year
FY2019: 2.7FY2021: 8.6FY2022: 1.8 (−79.3%)FY2023: 3.8 (+111.5%)FY2024: 2.5 (−33.7%)FY2025: 2.1 (−15.1%)FY2026: 6.8 (+221.0%)
FY2017FY2026
EV / EBITDA−87.9%
17.8
FY2026 · hover or tap a bar for each year
FY2019: 7.3FY2022: 53.6FY2024: 593.0FY2025: 147.1 (−75.2%)FY2026: 17.8 (−87.9%)
FY2017FY2026
Price / free cash flow+69.9%
31.9
FY2026 · hover or tap a bar for each year
FY2019: 17.7FY2025: 18.8FY2026: 31.9 (+69.9%)
FY2017FY2026
Free cash flow yield−2.2 pts
3.1%
FY2026 · hover or tap a bar for each year
FY2019: 5.6%FY2021: −0.9%FY2022: −1.8% (−0.9 pts)FY2023: −4.4% (−2.6 pts)FY2024: −6.6% (−2.2 pts)FY2025: 5.3% (+12.0 pts)FY2026: 3.1% (−2.2 pts)
FY2017FY2026

INNV valuation history

Fiscal year-endToday10-year median

INNV returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

INNV debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

INNV cash returned to shareholders

DividendsBuybacksFree cash flow

INNV price vs earnings per share

Share price at year-endEPS (right axis)

INNV key metrics

FY2017–FY2026
InnovAge Holding Corp. key metrics by fiscal year
FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Valuation
Market capitalization$1.61B$499.6M$674.1M$1.02B$593.6M$2.89B—$202.4M——
Enterprise value$1.55B$494.7M$684.3M$1.03B$493.9M$2.77B—$336.0M——
P/E ratio———————10.3——
Price / sales1.60.60.91.50.84.5—0.4——
Price / book6.82.12.53.81.88.6—2.7——
Price / free cash flow31.918.8—————17.7——
Price / operating cash flow24.815.2——21.7——7.8——
EV / sales1.60.60.91.50.74.3—0.7——
EV / EBITDA17.8147.1593.0—53.6——7.3——
EV / free cash flow30.818.6—————29.4——
Earnings yield−0.2%−6.1%−3.2%−4.0%−1.1%−1.5%—9.7%——
Free cash flow yield3.1%5.3%−6.6%−4.4%−1.8%−0.9%—5.6%——
Dividend yield————0.0%0.3%—32.9%——
Shareholder yield (dividends + buybacks)0.0%1.5%0.0%0.0%0.0%3.0%—32.9%——
Share price at fiscal year-end$11.85$3.69$4.96$7.50$4.38$21.31—$1.52$0.10$0.12
Per share
Revenue per share$7.29$6.31$5.62$5.07$5.16$4.71$4.26$3.50——
Earnings per share−$0.02−$0.22−$0.16−$0.30−$0.05−$0.32$0.20$0.15——
Operating cash flow per share$0.48$0.24−$0.27−$0.27$0.20−$0.06$0.33$0.19——
Free cash flow per share$0.37$0.20−$0.33−$0.33−$0.08−$0.20$0.24$0.09——
Cash per share$1.04$0.78$0.76$0.76$1.36$1.50$0.86$0.46——
Book value per share$1.74$1.74$1.98$1.99$2.45$2.47$0.76$0.56——
Tangible book value per share$0.67−$0.39$0.92$0.92$1.49$1.50−$0.15−$0.37——
Dividends per share————$0.00$0.07$0.07$0.50——
Capex per share$0.11$0.05$0.06$0.06$0.28$0.14$0.09$0.11——
Debt per share$0.64$0.75$0.83$0.83$0.63$0.61$1.64$1.46——
Shares outstanding135.7M135.4M135.9M135.6M135.5M135.5M133.2M133.2M——
Change in shares outstanding+0.2%−0.4%+0.2%+0.1%+0.0%+1.7%0.0%———
Returns & profitability
Return on equity (ROE)−1.1%−12.0%−7.9%−13.5%−2.0%−20.2%30.0%52.1%−651.4%—
Return on invested capital (ROIC)16.1%−9.2%−6.6%−15.2%−1.6%28.3%17.9%28.6%−350.0%−585.8%
Return on assets (ROA)−0.5%−5.3%−3.8%−7.3%−1.2%−9.3%6.8%10.5%−75.4%−188.0%
Return on tangible assets−0.6%−11.3%−4.9%−10.1%−1.5%−10.8%9.1%8.2%−170.9%−577.7%
Free cash flow margin5.1%3.1%−5.9%−6.5%−1.6%−4.2%5.6%2.5%−27.3%−38.0%
Income quality (OCF / net income)——————1.671.32——
Financial health
Total debt$87.0M$101.1M$113.0M$113.0M$84.8M$82.6M$218.0M$194.8M$1.3M$1.4M
Cash & short-term investments$141.3M$105.9M$102.8M$102.8M$184.4M$203.7M$114.6M$61.2M$1.6M$829,933
Net debt−$54.4M−$4.8M$10.2M$10.3M−$99.6M−$121.1M$103.4M$133.6M−$260,164$565,386
Debt / equity0.370.430.420.420.260.252.162.631.441.28
Debt / assets0.160.180.190.210.150.150.530.540.140.17
Net debt / EBITDA−0.62−1.448.88—−10.81—1.682.91——
Current ratio1.051.071.251.252.293.192.181.430.720.58
Quick ratio1.051.071.271.252.293.172.161.410.390.43
Interest coverage15.6-6.5-5.8-32.5-1.74.53.54.1——
Working capital$10.4M$11.3M$34.5M$34.5M$135.6M$172.4M$90.3M$36.0M−$1.4M−$1.7M
Invested capital$181.2M$230.1M$279.5M$279.5M$232.7M$213.5M$204.4M$207.8M$642,779$1.7M
Tangible asset value$123.5M−$25.1M$155.3M$155.3M$223.7M$227.2M−$13.6M−$41.7M−$4.3M−$4.8M
Net current asset value−$74.3M−$118.2M−$106.9M−$74.7M$31.8M$70.3M−$135.0M−$162.3M−$4.4M−$4.8M
Graham number——————$1.83$1.36——
Graham net-net per share−$0.83−$1.17−$1.03−$0.79$0.05$0.39−$1.13−$1.34——
Capital allocation
Dividends paid————$0$9.5M$9.5M$66.5M——
Share buybacks (net)$0$7.3M$179,000$179,000$0$77.6M$0$193,000$0$0
Dividend payout ratio——————36.2%339.7%——
Dividends + buybacks / free cash flow0.0%27.5%————29.7%584.1%——
Capex / revenue1.4%0.7%1.0%1.2%5.5%3.1%2.1%3.1%0.5%0.9%
Capex / operating cash flow22.1%19.1%——140.1%—27.0%55.9%——
Capex / depreciation0.680.320.420.512.751.591.051.610.070.07
Stock-based compensation / revenue0.7%0.9%0.9%1.0%0.5%0.3%0.1%0.2%——
R&D / revenue———————0.0%0.4%1.6%
SG&A / revenue16.8%17.6%17.8%19.7%18.0%20.7%13.7%13.9%136.4%197.0%
Efficiency
Days sales outstanding15.719.524.625.021.124.633.221.62.14.4
Days of inventory on hand——-1.0-0.10.71.51.41.7229.6143.9
Days payables outstanding44.889.732.033.026.923.525.416.8291.6119.8
Cash conversion cycle (days)-29.0-70.2-8.5-8.1-5.12.69.26.5-59.828.6
Receivables turnover23.1918.7414.8514.6217.3314.8311.0116.91173.1582.60
Payables turnover8.154.0711.3911.0713.5915.5514.3821.741.253.05
Inventory turnover————504.27244.42266.51217.751.592.54
Asset turnover1.781.501.351.241.271.351.472.501.020.66
Average receivables$42.7M$45.6M$51.4M$47.0M$40.3M$43.0M$51.5M$27.5M$50,917$58,336
Average payables$96.1M$66.1M$55.5M$53.0M$41.5M$30.6M$29.6M$16.3M$1.5M$355,454
Average inventory——−$1.8M−$131,000$1.1M$1.9M$1.6M$1.6M$1.2M$427,150
Intangibles / total assets26.1%51.7%24.9%26.4%23.1%24.3%29.6%33.9%57.9%71.2%

Computed from INNV's annual financial statements (latest annual report filed September 9, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

INNV valuation and financial ratios

InnovAge earned a return on equity of −1.1% and a return on invested capital of 16.1% in fiscal 2026. It ended the year with $87.0 million of debt and $141.3 million in cash and short-term investments, a net cash position of $54.4 million.

See the INNV income statement, the INNV chart for price history, or the INNV stock overview for the latest quote and news.

INNV key metrics FAQ

What is InnovAge's EV/EBITDA?

InnovAge's enterprise value was 17.8 times EBITDA at the end of fiscal 2026 (enterprise value $1.6 billion, EBITDA $87.4 million); the current EV/EBITDA is 45.7.

What is InnovAge's return on equity?

InnovAge's return on equity (ROE) was −1.1% in fiscal 2026: net income of -$2.5 million on average shareholders' equity of $235.3 million.

What is InnovAge's ROIC?

InnovAge's return on invested capital was 16.1% in fiscal 2026, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does InnovAge have?

InnovAge had total debt of $87.0 million at the end of fiscal 2026, a debt-to-equity ratio of 0.37 and more cash than debt.

What is InnovAge's free cash flow yield?

InnovAge generated $50.4 million of free cash flow in fiscal 2026, a free cash flow yield of 3.1% on its market value at year-end ($1.6 billion).

What is InnovAge's current ratio?

InnovAge's current ratio was 1.05 at the end of fiscal 2026: current assets were 1.05 times current liabilities.

Medical Care Facilities key metrics